Dassault Systèmes SE (DASTY)
| Previous close | 38.03 |
| Open | 37.96 |
| Bid | 37.96 x 40000 |
| Ask | 38.10 x 40000 |
| Day's range | 37.93 - 38.12 |
| 52-week range | 35.62 - 53.00 |
| Volume | |
| Avg. volume | 113,372 |
| Market cap | 49.93B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 41.45 |
| EPS (TTM) | 0.92 |
| Earnings date | 24 Oct 2024 |
| Forward dividend & yield | 0.25 (0.65%) |
| Ex-dividend date | 23 May 2024 |
| 1y target est | 43.09 |
Business WireEisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
NEW YORK, July 26, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Eisai Inc. ("Eisai"), the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Eisai Inc., will leverage this innovative data experience to gain unprecedented control over its clinical data, enable the execution of scalable and
GlobeNewswireDassault Systèmes: Availability of the 2024 Half-year Financial Report
Press ReleaseVELIZY-VILLACOUBLAY, France — July 25, 2024 Availability of Dassault Systèmes’ 2024 Half-Year Financial Report (IFRS Half-Year Consolidated Condensed Financial Statements) Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the availability to the public and the filing of its Half-Year Financial Report as of June 30, 2024 with the French Autorité des marchés financiers. The half-year condensed consolidated financial statements included in this report are establi
Business WireASICS and Dassault Systèmes Demonstrate On-Demand, Personalized Footwear
VELIZY-VILLACOUBLAY, France, July 25, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and ASICS have jointly opened a studio in Paris to test a new service providing on-demand sockliners personalized for individual foot shape.
